https://www.zonebourse.com/cours/action/ATYR-PHARMA-INC-60951391/actualite/Atyr-Pharma-Inc-annonce-le-dosage-du-premier-patient-de-l-etude-de-phase-2-Efzo-Connect-d-Efzof-45198913/?utm_source=telegram&utm_medium=social&utm_campaign=share